SENSORION has a total of 36 patent applications. It decreased the IP activity by 36.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CLEMENTIA PHARMACEUTICALS INC, STREMMEL WOLFGANG and MEDGENE BIOSCIENCE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | United States | 5 | |
#4 | China | 4 | |
#5 | Hong Kong | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Chile | 1 | |
#10 | Hungary | 1 | |
#11 | Israel | 1 | |
#12 | Japan | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Mexico | 1 | |
#15 | Singapore | 1 | |
#16 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dyhrfjeld-Johnsen Jonas | 13 |
#2 | Gaboyard-Niay Sophie | 6 |
#3 | Toronto Dawn | 5 |
#4 | Copmans Daan | 5 |
#5 | Mohr Amandine | 5 |
#6 | Bonten Maurice Hubert | 5 |
#7 | Wersinger Éric | 3 |
#8 | Wersinger Eric | 3 |
#9 | Jonas Dyhrfjeld-Johnsen | 2 |
#10 | Dyhrfjeld Johnsen Jonas | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021014014A1 | Treatment and/or prevention of lesions in the central auditory nervous system | |
CN111465602A | Synthesis of 4-aminopyrimidine compounds | |
KR20180129923A | (+) - azacetone for use in the treatment of ear disorders | |
MX2018012587A | (+)-azasetron for use in the treatment of ear disorders. | |
CN107847489A | For treating department's fine jade class Calcineurin inhibitors of hearing loss | |
EP2982382A1 | Compounds for preventing ototoxicity | |
EP3378476A1 | H4 receptor inhibitors for treating tinnitus | |
WO2013178763A1 | Methods for treating vestibulotoxicity |